| Primary |
| Product Used For Unknown Indication |
44.1% |
| Schizophrenia |
15.3% |
| Bipolar Disorder |
5.9% |
| Ill-defined Disorder |
4.5% |
| Psychotic Disorder |
4.5% |
| Attention Deficit/hyperactivity Disorder |
3.5% |
| Schizoaffective Disorder |
3.5% |
| Autism |
3.0% |
| Bipolar I Disorder |
2.5% |
| Depression |
2.5% |
| Obsessive-compulsive Disorder |
2.5% |
| Schizophrenia, Paranoid Type |
2.0% |
| Affective Disorder |
1.0% |
| Drug Therapy |
1.0% |
| Electroconvulsive Therapy |
1.0% |
| Hypertension |
1.0% |
| Vascular Dementia |
1.0% |
| Acute Psychosis |
0.5% |
| Aggression |
0.5% |
| Anxiety |
0.5% |
|
| Neuroleptic Malignant Syndrome |
14.3% |
| Completed Suicide |
11.4% |
| Memory Impairment |
8.6% |
| Catatonia |
5.7% |
| Dyskinesia |
5.7% |
| Floppy Iris Syndrome |
5.7% |
| Gastric Cancer |
5.7% |
| Physical Assault |
5.7% |
| Tremor |
5.7% |
| Activities Of Daily Living Impaired |
2.9% |
| Amenorrhoea |
2.9% |
| Antisocial Behaviour |
2.9% |
| Arrested Labour |
2.9% |
| Blood Prolactin Increased |
2.9% |
| Breast Feeding |
2.9% |
| Cardio-respiratory Arrest |
2.9% |
| Drooling |
2.9% |
| Drug Exposure During Pregnancy |
2.9% |
| Drug Interaction |
2.9% |
| Dysphagia |
2.9% |
|
| Secondary |
| Product Used For Unknown Indication |
40.8% |
| Tourette's Disorder |
9.8% |
| Schizophrenia |
7.8% |
| Ill-defined Disorder |
5.7% |
| Psychotic Disorder |
5.3% |
| Depression |
4.1% |
| Obsessive-compulsive Disorder |
4.1% |
| Schizophrenia, Paranoid Type |
4.1% |
| Anxiety |
2.4% |
| Delusional Disorder, Jealous Type |
2.4% |
| Major Depression |
2.4% |
| Attention Deficit/hyperactivity Disorder |
1.6% |
| Autism |
1.6% |
| Bipolar Disorder |
1.6% |
| Schizoaffective Disorder |
1.6% |
| Sleep Disorder |
1.2% |
| Affective Disorder |
0.8% |
| Anorexia Nervosa |
0.8% |
| Dyspepsia |
0.8% |
| Influenza Immunisation |
0.8% |
|
| Sedation |
23.9% |
| Completed Suicide |
17.9% |
| Weight Increased |
10.4% |
| Muscle Rigidity |
7.5% |
| Hypoaesthesia |
4.5% |
| Neuroleptic Malignant Syndrome |
4.5% |
| Vomiting |
4.5% |
| Amenorrhoea |
3.0% |
| Cardiac Arrest |
3.0% |
| Dyspnoea |
3.0% |
| Extrapyramidal Disorder |
3.0% |
| Tremor |
3.0% |
| Atelectasis |
1.5% |
| Blood Creatine Phosphokinase Increased |
1.5% |
| Breast Feeding |
1.5% |
| Breast Pain |
1.5% |
| Child Abuse |
1.5% |
| Drooling |
1.5% |
| Electrocardiogram Qt Prolonged |
1.5% |
| Epilepsy |
1.5% |
|
| Concomitant |
| Schizophrenia |
16.5% |
| Depression |
13.9% |
| Product Used For Unknown Indication |
11.3% |
| Suicide Attempt |
8.7% |
| Oropharyngeal Pain |
7.0% |
| Attention Deficit/hyperactivity Disorder |
5.2% |
| Cerebral Ischaemia |
4.3% |
| Renal Transplant |
4.3% |
| Bipolar Disorder |
3.5% |
| Drug Use For Unknown Indication |
3.5% |
| Hiv Infection |
3.5% |
| Bipolar I Disorder |
2.6% |
| Essential Hypertension |
2.6% |
| Hypertension |
2.6% |
| Asthma |
1.7% |
| Atrial Fibrillation |
1.7% |
| Chronic Obstructive Pulmonary Disease |
1.7% |
| Influenza Like Illness |
1.7% |
| Prophylaxis |
1.7% |
| Schizophrenia, Paranoid Type |
1.7% |
|
| Psychotic Disorder |
15.6% |
| Pharyngitis |
9.4% |
| Affect Lability |
6.3% |
| Death |
6.3% |
| Depressed Level Of Consciousness |
6.3% |
| Dysphagia |
6.3% |
| Pyrexia |
6.3% |
| White Blood Cell Count Increased |
6.3% |
| Abdominal Pain |
3.1% |
| Abdominal Pain Upper |
3.1% |
| Anaemia |
3.1% |
| Asthma |
3.1% |
| Bone Lesion |
3.1% |
| Cardiac Failure |
3.1% |
| Cervix Carcinoma |
3.1% |
| Chest Discomfort |
3.1% |
| Choking |
3.1% |
| Completed Suicide |
3.1% |
| Condition Aggravated |
3.1% |
| Delirium |
3.1% |
|
